ASND
Ascendis Pharma A/S
NASDAQHealthcareBiotechnologyDK
Rating:B-
Company Profile
CEO
Jan Moller Mikkelsen
IPO Date
2015-01-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
DK
Ascendis Pharma A/S
CEO
Jan Moller Mikkelsen
IPO Date
2015-01-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
DK
| 200 |
| $223.76 |
| 1 Jun 2026 | BIENAIME JEAN JACQUES | director | P-Purchase | Acquired | 200 | $222.30 |
| 1 Jun 2026 | BIENAIME JEAN JACQUES | director | P-Purchase | Acquired | 100 | $223.50 |
| 1 Jun 2026 | SMITH SCOTT THOMAS | EVP & Chief Financial Officer | P-Purchase | Acquired | 250 | $223.32 |
| 1 Jun 2026 | SMITH SCOTT THOMAS | EVP & Chief Financial Officer | Disposed | 0 | $0.00 |
| 27 May 2026 | BIENAIME JEAN JACQUES | director | P-Purchase | Acquired | 200 | $236.24 |
| 27 May 2026 | BIENAIME JEAN JACQUES | director | P-Purchase | Acquired | 200 | $239.37 |
| 12 May 2026 | JENSEN FLEMMING STEEN | See Remarks | S-Sale | Disposed | 19,460 | $238.49 |
| 1 Apr 2026 | BIENAIME JEAN JACQUES | director | Disposed | 0 | $0.00 |